Cancer Covered Blog

Advances in Hemophilia Treatment

This past year has seen a long-awaited improvement in the treatment of hemophilia A and B.

Regular use of prophylactic clotting factors has made vast improvements in the quality of life of boys and men diagnosed with hemophilia. With this use they can preserve joint health and participate in many sports and activities that were not previously possible. However to accomplish this requires patients to access their own veins and infuse themselves three or even more times a week. This has been improved in 2014.

In the last 12 months the FDA has now approved longer-acting Factor IX(used to treat hemophilia B) and Factor VIII(used to treat hemophilia A). This was accomplished by taking a protein found on antibodies and adding it to the clotting factors. This is much harder for the body to breakdown and the clotting factor now stays in the body for a longer period of time. In best case scenarios the new factor IX can be given as little as every 14 days.

Many other exciting products are still in development and further improvements are expected.

Dr. Matthew Ryan signature
Matthew Ryan, MD

Matthew has a knack for bringing people together and a caring way of making you feel safe and comfortable.

View all posts

Do you have an idea for a blog post or podcast? Share it with us!

We want to ensure that the information we provide you is relevant and helpful. If you there is a topic that you’d like to know about that is important to you, let us know. We’ll keep your information private.

Related Posts

Blog_Post-Melanoma
Read More
Dr_Winkler-New_725x500
Read More
Blog_Post-Survivorship
Read More
Dr_Winkler-New_725x500
Read More
Blog_Post-Lung_Cancer
Read More
Blog_Post-Prostate_Cancer
Read More